FDA
- Status: approved
🇺🇸 TRAVERT 10% IN PLASTIC CONTAINER in United States
TRAVERT 10% IN PLASTIC CONTAINER (INVERT SUGAR) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA016717
- Marketing authorisation holder: BAXTER HLTHCARE
- Local brand name: TRAVERT 10% IN PLASTIC CONTAINER
- Indication: INJECTABLE — INJECTION
- Status: approved
TRAVERT 10% IN PLASTIC CONTAINER in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is TRAVERT 10% IN PLASTIC CONTAINER approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for TRAVERT 10% IN PLASTIC CONTAINER in United States?
BAXTER HLTHCARE is the originator. The local marketing authorisation holder may differ — check the official source linked above.